Kaurene diterpene induces apoptosis in human leukemia cells partly through a caspase-8-dependent pathway

Masuo Kondoh, Ikue Suzuki, Masao Sato, Fumihiro Nagashima, Siro Simizu, Motoki Harada, Makiko Fujii, Hiroyuki Osada, Yoshinori Asakawa, Yoshiteru Watanabe

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Defects in apoptosis signaling pathways contribute to tumorigenesis and drug resistance, and these defects are often a cause of failure of chemotherapy. Thus, a major goal in chemotherapy is to find cytotoxic agents that restore the ability of tumor cells to undergo apoptosis. We previously found that an Ent-kaurene diterpene, Ent-11α-hydroxy-16-kauren-15-one (KD), induced apoptosis in human promyelocytic leukemia HL-60 cells. Here, we found that caspase-8, an apoptotic factor, is involved in KD-induced apoptosis. Although treatment of HL-60 cells with KD resulted in the activation of caspase-8 and -9, a caspase-8-specific inhibitor but not a caspase-9-specific inhibitor attenuated KD-induced apoptosis. Expression of a catalytically inactive caspase-8 partly attenuated KD-induced apoptosis. Treatment with KD led to a time-dependent cleavage of Bid, a substrate of caspase-8, as well as to the proteolytic processing of procaspase-8, indicating that KD treatment induces apoptosis through a caspase-8-dependent pathway. Moreover, overexpression of the drug resistance factor Bcl-2, which is frequently overexpressed in many tumors, failed to confer resistance to KD-induced cytotoxicity. Thus, KD may be a promising experimental cytotoxic agent that possibly points to new strategies to overcome a drug resistance.

Original languageEnglish
Pages (from-to)115-122
Number of pages8
JournalJournal of Pharmacology and Experimental Therapeutics
Volume311
Issue number1
DOIs
Publication statusPublished - 2004 Oct
Externally publishedYes

Fingerprint

Caspase 8
Diterpenes
Leukemia
Apoptosis
Drug Resistance
Caspase 9
HL-60 Cells
Cytotoxins
Kaurane Diterpenes
Drug Therapy
R Factors
kaurene
Neoplasms
Carcinogenesis
Therapeutics

ASJC Scopus subject areas

  • Pharmacology

Cite this

Kaurene diterpene induces apoptosis in human leukemia cells partly through a caspase-8-dependent pathway. / Kondoh, Masuo; Suzuki, Ikue; Sato, Masao; Nagashima, Fumihiro; Simizu, Siro; Harada, Motoki; Fujii, Makiko; Osada, Hiroyuki; Asakawa, Yoshinori; Watanabe, Yoshiteru.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 311, No. 1, 10.2004, p. 115-122.

Research output: Contribution to journalArticle

Kondoh, M, Suzuki, I, Sato, M, Nagashima, F, Simizu, S, Harada, M, Fujii, M, Osada, H, Asakawa, Y & Watanabe, Y 2004, 'Kaurene diterpene induces apoptosis in human leukemia cells partly through a caspase-8-dependent pathway', Journal of Pharmacology and Experimental Therapeutics, vol. 311, no. 1, pp. 115-122. https://doi.org/10.1124/jpet.104.069690
Kondoh, Masuo ; Suzuki, Ikue ; Sato, Masao ; Nagashima, Fumihiro ; Simizu, Siro ; Harada, Motoki ; Fujii, Makiko ; Osada, Hiroyuki ; Asakawa, Yoshinori ; Watanabe, Yoshiteru. / Kaurene diterpene induces apoptosis in human leukemia cells partly through a caspase-8-dependent pathway. In: Journal of Pharmacology and Experimental Therapeutics. 2004 ; Vol. 311, No. 1. pp. 115-122.
@article{34aab50de357457ca52524b35e2012f5,
title = "Kaurene diterpene induces apoptosis in human leukemia cells partly through a caspase-8-dependent pathway",
abstract = "Defects in apoptosis signaling pathways contribute to tumorigenesis and drug resistance, and these defects are often a cause of failure of chemotherapy. Thus, a major goal in chemotherapy is to find cytotoxic agents that restore the ability of tumor cells to undergo apoptosis. We previously found that an Ent-kaurene diterpene, Ent-11α-hydroxy-16-kauren-15-one (KD), induced apoptosis in human promyelocytic leukemia HL-60 cells. Here, we found that caspase-8, an apoptotic factor, is involved in KD-induced apoptosis. Although treatment of HL-60 cells with KD resulted in the activation of caspase-8 and -9, a caspase-8-specific inhibitor but not a caspase-9-specific inhibitor attenuated KD-induced apoptosis. Expression of a catalytically inactive caspase-8 partly attenuated KD-induced apoptosis. Treatment with KD led to a time-dependent cleavage of Bid, a substrate of caspase-8, as well as to the proteolytic processing of procaspase-8, indicating that KD treatment induces apoptosis through a caspase-8-dependent pathway. Moreover, overexpression of the drug resistance factor Bcl-2, which is frequently overexpressed in many tumors, failed to confer resistance to KD-induced cytotoxicity. Thus, KD may be a promising experimental cytotoxic agent that possibly points to new strategies to overcome a drug resistance.",
author = "Masuo Kondoh and Ikue Suzuki and Masao Sato and Fumihiro Nagashima and Siro Simizu and Motoki Harada and Makiko Fujii and Hiroyuki Osada and Yoshinori Asakawa and Yoshiteru Watanabe",
year = "2004",
month = "10",
doi = "10.1124/jpet.104.069690",
language = "English",
volume = "311",
pages = "115--122",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Kaurene diterpene induces apoptosis in human leukemia cells partly through a caspase-8-dependent pathway

AU - Kondoh, Masuo

AU - Suzuki, Ikue

AU - Sato, Masao

AU - Nagashima, Fumihiro

AU - Simizu, Siro

AU - Harada, Motoki

AU - Fujii, Makiko

AU - Osada, Hiroyuki

AU - Asakawa, Yoshinori

AU - Watanabe, Yoshiteru

PY - 2004/10

Y1 - 2004/10

N2 - Defects in apoptosis signaling pathways contribute to tumorigenesis and drug resistance, and these defects are often a cause of failure of chemotherapy. Thus, a major goal in chemotherapy is to find cytotoxic agents that restore the ability of tumor cells to undergo apoptosis. We previously found that an Ent-kaurene diterpene, Ent-11α-hydroxy-16-kauren-15-one (KD), induced apoptosis in human promyelocytic leukemia HL-60 cells. Here, we found that caspase-8, an apoptotic factor, is involved in KD-induced apoptosis. Although treatment of HL-60 cells with KD resulted in the activation of caspase-8 and -9, a caspase-8-specific inhibitor but not a caspase-9-specific inhibitor attenuated KD-induced apoptosis. Expression of a catalytically inactive caspase-8 partly attenuated KD-induced apoptosis. Treatment with KD led to a time-dependent cleavage of Bid, a substrate of caspase-8, as well as to the proteolytic processing of procaspase-8, indicating that KD treatment induces apoptosis through a caspase-8-dependent pathway. Moreover, overexpression of the drug resistance factor Bcl-2, which is frequently overexpressed in many tumors, failed to confer resistance to KD-induced cytotoxicity. Thus, KD may be a promising experimental cytotoxic agent that possibly points to new strategies to overcome a drug resistance.

AB - Defects in apoptosis signaling pathways contribute to tumorigenesis and drug resistance, and these defects are often a cause of failure of chemotherapy. Thus, a major goal in chemotherapy is to find cytotoxic agents that restore the ability of tumor cells to undergo apoptosis. We previously found that an Ent-kaurene diterpene, Ent-11α-hydroxy-16-kauren-15-one (KD), induced apoptosis in human promyelocytic leukemia HL-60 cells. Here, we found that caspase-8, an apoptotic factor, is involved in KD-induced apoptosis. Although treatment of HL-60 cells with KD resulted in the activation of caspase-8 and -9, a caspase-8-specific inhibitor but not a caspase-9-specific inhibitor attenuated KD-induced apoptosis. Expression of a catalytically inactive caspase-8 partly attenuated KD-induced apoptosis. Treatment with KD led to a time-dependent cleavage of Bid, a substrate of caspase-8, as well as to the proteolytic processing of procaspase-8, indicating that KD treatment induces apoptosis through a caspase-8-dependent pathway. Moreover, overexpression of the drug resistance factor Bcl-2, which is frequently overexpressed in many tumors, failed to confer resistance to KD-induced cytotoxicity. Thus, KD may be a promising experimental cytotoxic agent that possibly points to new strategies to overcome a drug resistance.

UR - http://www.scopus.com/inward/record.url?scp=4644235277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644235277&partnerID=8YFLogxK

U2 - 10.1124/jpet.104.069690

DO - 10.1124/jpet.104.069690

M3 - Article

C2 - 15161936

AN - SCOPUS:4644235277

VL - 311

SP - 115

EP - 122

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -